Skip to content
Leading the way in de-risking clinical development with Al
Solutions
SaaS Products
Portfolio Optimizer
Dynamic Benchmarks
Data & Insights
Who We Work With
Resources
About
Careers
Request a Demo
Solutions
SaaS Products
Portfolio Optimizer
Dynamic Benchmarks
Data & Insights
Who We Work With
Resources
About
Careers
Request a Demo
Request a Demo
Intelligencia AI Appoints Névine Zariffa as Scientific Advisory Board Chair
Alexandra Ferraro
November 6, 2023
De-risk clinical development and enhance decision-making with accurate, AI-driven probability of success.
Let’s Talk
Related Insights
The Insight Drop | Cell Therapy in Multiple Sclerosis: A Market Signal in Search of Proof
Read More
5 Portfolio Management Lessons Learned from the Strategic PPM for Pharma Conference
Read More
The Insight Drop | Regulatory Designations in Oncology: Signal or Substance?
Read More
Testing....
